SuperSeton is proud to have been selected as one of the HUB Promising Life Science Companies. This dedicated program is providing Dutch life science startups and emerging companies with successful entry to the U.S. healthcare market. With masterclasses from successful entrepreneurs and senior industry leaders, coaching from the HUB team and partners, and peer-to-peer learning with the other participants, the HUB program will strategically prepare SuperSeton for its US market entry.
We are excited to take these steps to add the US market to our reach. It will allow us to provide access to SuperSeton’s knotless innovation to another large group of patients and doctors.
More info on the Holland US Bridge program can be found at hollandusbridge.com/.